**5. References**


from failure to demonstrate an expected therapeutic effect, to an adverse reaction resulting in significant patient morbidity and mortality, decreasing quality of life, as well as

The goal of the emerging disciplines of pharmacogenomics is to personalize therapy based on an individual's genotype. To date, the success of PGx has spread across all fields of medicine, although little is known about the genetic profile and its correlation with treatment response and overall survival in nasopharyngeal cancer patients. Genetic information has been used in the identification of disease risk, choice of treatment agents and guiding drug dosing. This is particularly important for chemotherapeutic agents, which in general affect both tumor and non-tumor cells and thus have a narrow therapeutic index, with the potential for life-threatening toxicity. Future work should explore the role of genetic variations in nasopharyngeal cancer patients, in a pharmacogenomics approach.

Al-Sarraf, M, M LeBlanc, PG Giri, KK Fu, J Cooper, T Vuong, AA Forastiere, G Adams, WA

Beasly, N, Ed. (2008). Anatomy of the pharynx and oesophagus. Scott-Brown's

Begum, S and WH Westra (2008). Basaloid squamous cell carcinoma of the head and neck is

Bhatia, KS, AD King, BK Paunipagar, J Abrigo, AC Vlantis, SF Leung and AT Ahuja (2009).

Bomken, S, K Fiser, O Heidenreich and J Vormoor (2010). Understanding the cancer stem

Brady, LW, H-P Heilman, M Molls and C Nieder, Eds. (2010). Nasopharyngeal Cancer

Bray, F, M Haugen, TA Moger, S Tretli, OO Aalen and T Grotmol (2008). Age-incidence

Braz-Silva, PH, S Vitale, C Butori, N Guevara, J Santini, M Magalhaes, P Hofman and A

Breda, E, R Catarino, I Azevedo, T Fernandes, C Barreira da Costa and R Medeiros (2007).

Breda, E, R Catarino, A Coelho, H Sousa and R Medeiros (2008). [Nasopharyngeal

Portuguese population]. *Acta Otorrinolaringol Esp* 58(5): 191-197.

study 0099. *J Clin Oncol* 16(4): 1310-1317.

cell. *Br J Cancer* 103(4): 439-445.

Radiation Oncology, Springer.

Otolaryngology Head and Neck Surgery London.

nasopharyngeal carcinoma. *Eur Radiol* 19(11): 2586-2593.

Sakr, DE Schuller and JF Ensley (1998). Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup

a mixed variant that can be further resolved by HPV status. *Am J Surg Pathol* 32(7):

MRI findings in patients with severe trismus following radiotherapy for

Multidisciplinary Management. Medical Radiology diagnostic Imaging and

curves of nasopharyngeal carcinoma worldwide: bimodality in low-risk populations and aetiologic implications. *Cancer Epidemiol Biomarkers Prev* 17(9):

Doglio (2011). Specific infiltration of langerin-positive dendritic cells in EBVinfected tonsil, Hodgkin lymphoma and nasopharyngeal carcinoma. *Int J Cancer*

[Characterization of the clinical evolution of nasopharyngeal carcinoma in

carcinoma study: introduction and multidisciplinary perspective]. *Acta Med Port*

increasing healthcare costs.

**5. References** 

1044-1050.

2356-2365.

128(10): 2501-2508.

21(3): 273-284.


polymorphisms of DNA repair enzymes XRCC1 and hOGG1. *Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology* 12(10): 1100-1104.

Nasopharyngeal Cancer – An Expanding Puzzle – Claiming for Answers 243

Henle, G and W Henle (1976). Epstein-Barr virus-specific IgA serum antibodies as an

Henle, G, W Henle and V Diehl (1968). Relation of Burkitt's tumor-associated herpes-ytpe

Henle, W and G Henle (1976). The sero-epidemiology of Epstein-Barr virus. *Advances in* 

Henle, W, G Henle, M Scriba, CR Joyner, FS Harrison, Jr., R Von Essen, J Paloheimo and E

Hildesheim, A, LM Anderson, CJ Chen, YJ Cheng, LA Brinton, AK Daly, CD Reed, IH Chen,

Hildesheim, A and PH Levine (1993). Etiology of nasopharyngeal carcinoma: a review.

Hui, AB, KW Lo, PM Teo, KF To and DP Huang (2002). Genome wide detection of oncogene

IARC, Ed. (2005). Pathology and Genetics of Head and Neck Tumours. Who Health

Jackson, C (1901). Primary carcinoma of the nasopharynx: a table of cases. *JAMA*(37): 371-

Jeffery, N (2005). Cranial base angulation and growth of the human fetal pharynx. *Anat Rec* 

Jiong, L, F Berrino and JW Coebergh (1998). Variation in survival for adults with Nasopharyngeal cancer in Europe, 1978-1989. *Eur J Cancer* 34(14): 2162-2166. Kalaitzidis, D and TD Gilmore (2005). Transcription factor cross-talk: the estrogen receptor

Kong, QL, LJ Hu, JY Cao, YJ Huang, LH Xu, Y Liang, D Xiong, S Guan, BH Guo, HQ Mai,

Lee, N, J Harris, AS Garden, W Straube, B Glisson, P Xia, W Bosch, WH Morrison, J Quivey,

Therapy Oncology Group Phase II Trial 0225. *Journal of Clinical Oncology* 27.

cancer cells in nasopharyngeal carcinoma. *PLoS Pathog* 6(6): e1000940. Lee, AW, WM Sze, JS Au, SF Leung, TW Leung, DT Chua, BC Zee, SC Law, PM Teo, SY

QY Chen, X Zhang, MZ Li, JY Shao, CN Qian, YF Xia, LB Song, YX Zeng and MS Zeng (2010). Epstein-Barr virus-encoded LMP2A induces an epithelialmesenchymal transition and increases the number of side population stem-like

Tung, DL Kwong and WH Lau (2005). Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. *Int J Radiat Oncol Biol* 

W Thorstad, C Jones and KK Ang (2009). Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation

Taiwan. *Journal of the National Cancer Institute* 89(16): 1207-1212.

hybridization. *International journal of oncology* 20(3): 467-473.

Organization Classification of Tumours, Lyon.

and NF-kappaB. *Trends Endocrinol Metab* 16(2): 46-52.

*A Discov Mol Cell Evol Biol* 284(1): 491-499.

*Journal international du cancer* 17(1): 1-7.

*the United States of America* 59(1): 94-101.

*pathobiology*(5): 5-17.

377.

*Phys* 61(4): 1107-1116.

*medicine* 282(19): 1068-1074.

*Epidemiologic reviews* 15(2): 466-485.

outstanding feature of nasopharyngeal carcinoma. *International journal of cancer.* 

virus to infectious mononucleosis. *Proceedings of the National Academy of Sciences of* 

Klemola (1970). Antibody responses to the Epstein-Barr virus and cytomegaloviruses after open-heart and other surgery. *The New England journal of* 

NE Caporaso, MM Hsu, JY Chen, JR Idle, RN Hoover, CS Yang and SK Chhabra (1997). CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in

amplifications in nasopharyngeal carcinoma by array based comparative genomic


*cosponsored by the American Society of Preventive Oncology* 12(10): 1100-1104. Clarke, MF, JE Dick, PB Dirks, CJ Eaves, CH Jamieson, DL Jones, J Visvader, IL Weissman

d'Espiney Amaro, C, P Montalvao, P Henriques, M Magalhaes and J Olias (2009).

Daniel G. Deschler, TD, Ed. (2008). Pocket Guide To TNM STAGING OF HEAD AND

Epstein, MA, BG Achong and YM Barr (1964). Virus Particles in Cultured Lymphoblasts

Ereno, C, A Gaafar, M Garmendia, C Etxezarraga, FJ Bilbao and JI Lopez (2008). Basaloid

study of 40 cases and review of the literature. *Head Neck Pathol* 2(2): 83-91. Fang, FM, WL Tsai, TF Lee, KC Liao, HC Chen and HC Hsu (2010). Multivariate analysis of

Farrell, PJ (1995). Epstein-Barr virus immortalizing genes. *Trends in microbiology* 3(3): 105-

Fukuyama, S, T Nagatake, D-Y Kim, K Takamura, EJ Park, T Kaisho, N Tanaka, Y Kurono

Ghisletti, S, C Meda, A Maggi and E Vegeto (2005). 17beta-estradiol inhibits inflammatory

Groome, PA, KM Schulze, WJ Mackillop, B Grice, C Goh, BJ Cummings, SF Hall, FF Liu, D

Haddad, R, Ed. (2011). Multidisciplinary Management of Head and Neck Cancer, Demos

Henle, G and W Henle (1966). Immunofluorescence in cells derived from Burkitt's

Lymphoid Tissue Organogenesis. *J Immunol* (177): 4276-4280.

from Burkitt's Lymphoma. *Lancet* 1(7335): 702-703.

821-838.

*Immunol* 70(1): 45-48.

*Radiother Oncol* 97(2): 263-269.

tonsillar region. *Cancer* 92(6): 1484-1494.

lymphoma. *Journal of bacteriology* 91(3): 1248-1256.

838.

109.

25(8): 2957-2968.

Medical Publishing, LLC.

polymorphisms of DNA repair enzymes XRCC1 and hOGG1. *Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research,* 

and GM Wahl (2006). Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. *Cancer Res* 66(19): 9339-9344. Cvitkovic, E, M Bachouchi and JP Armand (1991). Nasopharyngeal carcinoma. Biology,

natural history, and therapeutic implications. *Hematol Oncol Clin North Am* 5(4):

Nasopharyngeal carcinoma: our experience. *Eur Arch Otorhinolaryngol* 266(6): 833-

NECK CANCER AND NECK DISSECTION CLASSIFICATION. , Alexandria, American Academy of Otolaryngology–Head and Neck Surgery Foundation, Inc. Douik, H, A Ben Chaaben, N Attia Romdhane, HB Romdhane, T Mamoghli, C Fortier, W

Boukouaci, L Harzallah, A Ghanem, S Gritli, M Makni, D Charron, R Krishnamoorthy, F Guemira and R Tamouza (2009). Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population. *Hum* 

squamous cell carcinoma of the head and neck: a clinicopathological and follow-up

quality of life outcome for nasopharyngeal carcinoma patients after treatment.

and H Kiyono (2006). Cutting Edge: Uniqueness of Lymphoid Chemokine Requirement for the Initiation and Maturation of Nasopharynx-Associated

gene expression by controlling NF-kappaB intracellular localization. *Mol Cell Biol*

Payne, DM Rothwell, JN Waldron, PR Warde and B O'Sullivan (2001). A comparison of published head and neck stage groupings in carcinomas of the


Nasopharyngeal Cancer – An Expanding Puzzle – Claiming for Answers 245

Parkin DM, BF, Ferlay J, Pisani P (2002). Global cancer statistics. *CA Cancer J Clin. 2005 :*

Pathmanathan, R, U Prasad, R Sadler, K Flynn and N Raab-Traub (1995). Clonal

Rainger, R (1997). Everett C. Olson and the development of vertebrate paleoecology and

Ripple, MO, WF Henry, SR Schwarze, G Wilding and R Weindruch (1999). Effect of

Saddlet, TW, Ed. (2009). Langman's Medical Embriology. Philadelphia, Lippincott Wiliams

Shao, JY, YH Li, HY Gao, QL Wu, NJ Cui, L Zhang, G Cheng, LF Hu, I Ernberg and YX Zeng

Shikina, T, T Hiroi, K Iwatani, MH Jang, S Fukuyama, M Tamura, H Ishikawa, T Kubo and

Sixbey, JW, JG Nedrud, N Raab-Traub, RA Hanes and JS Pagano (1984). Epstein-Barr virus

Snow Jr, JB and J Ballenger, Eds. (2003). Ballenger's Otorhinolaryngology Head and Neck

Song, LB, J Li, WT Liao, Y Feng, CP Yu, LJ Hu, QL Kong, LH Xu, X Zhang, WL Liu, MZ Li, L

Sousa, H, E Breda, AM Santos, R Catarino, D Pinto and R Medeiros (2011). Genetic risk

Sousa, H, M Pando, E Breda, R Catarino and R Medeiros (2011). Role of the MDM2 SNP309

Sousa, H, AM Santos, R Catarino, D Pinto, A Vasconcelos, C Lopes, E Breda and R Medeiros

*official journal of the European Cancer Prevention Organisation* 15(4): 362-366.

marker of clonal cellular proliferation. *Cell* 47(6): 883-889.

prostate carcinoma cells. *J Natl Cancer Inst* 91(14): 1227-1232.

taphonomy. *Archives of Natural History* 24(3): 373 - 396.

nasopharyngeal carcinoma. *Cancer* 100(6): 1162-1170.

Airways and Gut. *The Journal of Immunology* 172: 6259–6264.

nasopharyngeal epithelial cells. *J Clin Invest* 119(12): 3626-3636.

308G >A polymorphism. *DNA and cell biology* 30(2): 99-103.

carcinoma. *Molecular carcinogenesis* 50(2): 73-79.

Standring, S, Ed. (2008). Gray's Anatomy, Curchill Livingstone Elsevier.

Saddlet T, Ed. (1995). Langman's Medical Embryology.

proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. *The New England journal of medicine* 333(11): 693-698. Raab-Traub, N and K Flynn (1986). The structure of the termini of the Epstein-Barr virus as a

antioxidants on androgen-induced AP-1 and NF-kappaB DNA-binding activity in

(2004). Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with

H Kiyono (2004). IgA Class Switch Occurs in the Organized Nasopharynx- and Gut-Associated Lymphoid Tissue, but Not in the Diffuse Lamina Propria of

replication in oropharyngeal epithelial cells. *The New England journal of medicine*

Zhang, TB Kang, LW Fu, WL Huang, YF Xia, SW Tsao, M Li, V Band, H Band, QH Shi, YX Zeng and MS Zeng (2009). The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human

markers for nasopharyngeal carcinoma in Portugal: tumor necrosis factor alpha -

polymorphism in the initiation and early age of onset of nasopharyngeal

(2006). Linkage of TP53 codon 72 pro/pro genotype as predictive factor for nasopharyngeal carcinoma development. *European journal of cancer prevention : the* 

Mar-Apr;55(2): 74-108.

&Wilkins.

310(19): 1225-1230.

Surgery. Ontario, BC Decker Inc.


Leung, TW, SY Tung, WK Sze, FC Wong, KK Yuen, CM Lui, SH Lo, TY Ng and SK O (2005).

Lin, JC, KY Chen, WY Wang, JS Jan, WM Liang, CS Tsai and YH Wei (2001). Detection of

List, MA and J Stracks (2000). Evaluation of quality of life in patients definitively treated for squamous carcinoma of the head and neck. *Curr Opin Oncol* 12(3): 215-220. Liu, MZ, LL Tang, JF Zong, Y Huang, Y Sun, YP Mao, LZ Liu, AH Lin and J Ma (2008).

and proposed improvement. *Int J Radiat Oncol Biol Phys* 70(4): 1115-1123. Lo, KW and DP Huang (2002). Genetic and epigenetic changes in nasopharyngeal

Lo, KW, KF To and DP Huang (2004). Focus on nasopharyngeal carcinoma. *Cancer Cell* 5(5):

Lo, YM, AT Chan, LY Chan, SF Leung, CW Lam, DP Huang and PJ Johnson (2000).

Lu, SJ, NE Day, L Degos, V Lepage, PC Wang, SH Chan, M Simons, B McKnight, D Easton,

Marks, JE, JL Phillips and HR Menck (1998). The National Cancer Data Base report on the

Molinero, LL, MB Fuertes, MV Girart, L Fainboim, GA Rabinovich, MA Costas and NW

Nazar-Stewart, V, TL Vaughan, RD Burt, C Chen, M Berwick and GM Swanson (1999).

Niedobitek, G, ML Hansmann, H Herbst, LS Young, D Dienemann, CA Hartmann, T Finn, S

nasopharynx are regularly associated with the virus. *J Pathol* 165(1): 17-24. Niedobitek, G, ML Hansmann, H Herbst, LS Young, D Dienemann, CA Hartmann, T Finn, S

A gene in activated T lymphocytes. *J Immunol* 173(9): 5583-5590.

circulating Epstein-Barr virus DNA. *Cancer research* 60(24): 6878-6881. Lo, YM, SF Leung, LY Chan, AT Chan, KW Lo, PJ Johnson and DP Huang (2000). Kinetics of

survival and failure patterns. *Head Neck* 27(7): 555-565.

carcinoma. *Seminars in cancer biology* 12(6): 451-462.

carcinoma. *Cancer research* 60(9): 2351-2355.

carcinoma. *Cancer* 83(3): 582-588.

locus to the HLA region. *Nature* 346(6283): 470-471.

2607-2615.

423-428.

547-551.

17-24.

Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of

Epstein-Barr virus DNA in the peripheral-blood cells of patients with nasopharyngeal carcinoma: relationship to distant metastasis and survival. *Journal of clinical oncology : official journal of the American Society of Clinical Oncology* 19(10):

Evaluation of sixth edition of AJCC staging system for nasopharyngeal carcinoma

Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of

plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal

Y Zeng and et al. (1990). Linkage of a nasopharyngeal carcinoma susceptibility

relationship of race and national origin to the histology of nasopharyngeal

Zwirner (2004). NF-kappa B regulates expression of the MHC class I-related chain

Glutathione S-transferase M1 and susceptibility to nasopharyngeal carcinoma. *Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology* 8(6):

Pitteroff, A Welt, I Anagnostopoulos and et al. (1991). Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the

Pitteroff, A Welt, I Anagnostopoulos and et al. (1991). Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. *The Journal of pathology* 165(1):


Thompson, MP and R Kurzrock (2004). Epstein-Barr virus and cancer. *Clinical cancer* 

Tian, W, DA Boggs, WZ Ding, DF Chen and PA Fraser (2001). MICA genetic polymorphism

Tian, W, XM Zeng, LX Li, HK Jin, QZ Luo, F Wang, SS Guo and Y Cao (2006). Gender-

Tiwawech, D, P Srivatanakul, A Karalak and T Ishida (2006). Cytochrome P450 2A6 polymorphism in nasopharyngeal carcinoma. *Cancer letters* 241(1): 135-141. Van Hasselt, CA and AG Gibb, Eds. (1999). Nasopharyngeal Carcinoma Hong Kong,

Vasef, MA, A Ferlito and LM Weiss (1997). Nasopharyngeal carcinoma, with emphasis on its relationship to Epstein-Barr virus. *Ann Otol Rhinol Laryngol* 106(4): 348-356. Wain, SL, R Kier, RT Vollmer and EH Bossen (1986). Basaloid-squamous carcinoma of the

Wu, SB, SJ Hwang, AS Chang, T Hsieh, MM Hsu, RP Hsieh and CJ Chen (1989). Human

Young, LS and AB Rickinson (2004). Epstein-Barr virus: 40 years on. *Nature reviews. Cancer*

Zhang, F and J Zhang (1999). Clinical hereditary characteristics in nasopharyngeal carcinoma through Ye-Liang's family cluster. *Chin Med J (Engl)* 112(2): 185-187. Zhang, S, Y Wu, Y Zeng, L Zech and G Klein (1982). Cytogenetic studies on an epithelioid cell line derived from nasopharyngeal carcinoma. *Hereditas* 97(1): 23-28. Zhu, XN, R Chen, FH Kong and W Liu (1990). Human leukocyte antigens -A, -B, -C, and -

zur Hausen, H, H Schulte-Holthausen, G Klein, W Henle, G Henle, P Clifford and L

carcinomas of the nasopharynx. *Nature* 228(5276): 1056-1058.

tongue, hypopharynx, and larynx: report of 10 cases. *Hum Pathol* 17(11): 1158-1166.

leukocyte antigen (HLA) frequency among patients with nasopharyngeal

DR and nasopharyngeal carcinoma in northern China. *Ann Otol Rhinol Laryngol*

Santesson (1970). EBV DNA in biopsies of Burkitt tumours and anaplastic

southern Chinese Han population. *Immunogenetics* 58(2-3): 113-121.

Wei, WI and JS Sham (2005). Nasopharyngeal carcinoma. *Lancet* 365(9476): 2041-2054. Wenig, BM (1999). Nasopharyngeal carcinoma. *Ann Diagn Pathol* 3(6): 374-385.

carcinoma in Taiwan. *Anticancer Res* 9(6): 1649-1653.

821.

*Immunogenetics* 53(9): 724-728.

Greenwich Medical Media Ltd.

4(10): 757-768.

99(4 Pt 1): 286-287.

*research: an official journal of the American Association for Cancer Research* 10(3): 803-

and linkage disequilibrium with HLA-B in 29 African-American families.

specific associations between MICA-STR and nasopharyngeal carcinoma in a
